[1]何 创,王海燕,肖建斌,等.Caveolin-1在内毒素性肺损伤所致的肺纤维化中的表达及临床意义[J].医学信息,2020,33(13):65-68.[doi:10.3969/j.issn.1006-1959.2020.13.018]
　HE Chuang,WANG Hai-yan,XIAO Jian-bin,et al.Caveolin-1 Expression and Clinical Significance in Pulmonary Fibrosis Caused by Endotoxic Lung Injury[J].Medical Information,2020,33(13):65-68.[doi:10.3969/j.issn.1006-1959.2020.13.018]
点击复制

Caveolin-1在内毒素性肺损伤所致的肺纤维化中的表达及临床意义()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年13期
页码:
65-68
栏目:
论著
出版日期:
2020-07-01

文章信息/Info

Title:
Caveolin-1 Expression and Clinical Significance in Pulmonary Fibrosis Caused by Endotoxic Lung Injury
文章编号:
1006-1959（2020）13-0065-04
作者:
何 创; 王海燕; 肖建斌; 等
（1.广州中医药大学第二附属医院麻醉科，广东 广州 510120；2.苏北人民医院麻醉科，江苏 扬州 225000；3.广州市中西医结合医院乳腺科，广东 广州 510120）
Author(s):
HE Chuang; WANG Hai-yan; XIAO Jian-bin; et al
(1.Department of Anesthesiology,the Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Guangzhou 510120,Guangdong,China;2.Department of Anesthesiology,North Jiangsu People’s Hospital,Yangzhou 225000,Jiangsu,China;3.Depar
关键词:
急性肺损伤; 肺纤维化; Ⅰ型转移生长因子受体; 小窝蛋白-1
Keywords:
Acute lung injury; Pulmonary fibrosis; Type Ⅰ metastasis growth factor receptor;  Caveolin-1
分类号:
R563.8
DOI:
10.3969/j.issn.1006-1959.2020.13.018
文献标志码:
A
摘要:
目的 探讨小窝蛋白-1（Caveolin-1）在内毒素（LPS）性肺损伤所致的肺纤维化中的表达及临床意义。方法 选择健康雄性SD成年大鼠60只，随机分成对照组、模型组和干预组，各20只。对照组尾静脉注射生理盐水2 ml，模型组、干预组均采用LPS 5 mg/kg以生理盐水稀释至2 ml尾静脉注射，诱导肺损伤纤维化模型，干预组在给予诱导前经尾静脉先给予TGF-β1抗体2 μg/100 g，给药后第1、5、14、21天分别处死每组SD大鼠5只，取大鼠肺组织行HE染色观察病理变化，免疫组化方法检测肺组织内的肺组织胶原蛋白活性（Hpy）、Ⅰ型转移生长因子受体（TβRⅠ）以及Caveolin-1的表达情况。结果 ①对照组肺泡结构基本正常，肺泡腔内无明显渗出及炎症细胞浸润；模型组第1天以急性肺泡炎症为主，第5天时肺泡炎症较前有所减轻，第14天时开始出现肺纤维化，第21天时出现广泛肺纤维化；干预组病理改变与模型组呈同一规律，但肺泡炎症和肺纤维化程度轻于模型组；②给药后第1、5、14、21天，模型组和干预组Hpy表达均高于对照组，干预组第5、9、14天低于模型组，差异有统计学意义（P＜0.05）；模型组与干预组肺组织TβRⅠ表达均高于对照组，模型组第14、21天高于干预组，差异有统计学意义（P＜0.05）；模型组与干预组血清Caveolin-1水平低于对照组，且干预组高于模型组，差异有统计学意义（P＜0.05）。结论 Caveolin-1可减轻内毒素性肺损伤的程度，并能抑制纤维化过程，具有一定的肺保护作用。
Abstract:
Objective To investigate the expression and clinical significance of Caveolin-1 in pulmonary fibrosis caused by endotoxin (LPS) lung injury.Methods 60 healthy male male SD rats were randomly divided into control group, model group and intervention group, 20 rats each. The control group was injected with 2 ml of normal saline. The model group and the intervention group were injected with LPS 5 mg/kg diluted with normal saline to 2 ml of the tail vein to induce the lung injury fibrosis model. The intervention group passed the tail vein before induction. TGF-β1 antibody was given 2 μg/100 g, and 5 SD rats in each group were killed on days 1, 5, 14 and 21 after administration. The lung tissues of the rats were taken for HE staining to observe pathological changes and detected by immunohistochemistry Lung tissue collagen activity (Hpy), type Ⅰ transfer growth factor receptor TβRⅠ and Caveolin-1 expression in lung tissue.Results ①The alveolar structure of the control group was basically normal, and there was no obvious exudation and infiltration of inflammatory cells in the alveolar cavity; the model group was dominated by acute alveolar inflammation on the first day, and the alveolar inflammation was lessened on the fifth day than before, and pulmonary fibers began to appear on the 14th day pulmonary fibrosis occurred on the 21st day; the pathological changes of the intervention group were the same as the model group, but the degree of alveolar inflammation and pulmonary fibrosis was lighter than that of the model group;②On days 1, 5, 14, and 21 after administration, the Hpy expression of the model group and the intervention group was higher than that of the control group, and the intervention group was lower than that of the model group on days 5, 9, and 14,the difference was statistically significant (P<0.05); the lung tissue TβRⅠexpression of the model group and the intervention group was higher than that of the control group, and the model group was higher than that of the intervention group on days 14 and 21, the difference was statistically significant (P<0.05); Serum Caveolin-1 levels in the model group and the intervention group were lower than the control group, and the intervention group was higher than the model group,the difference was statistically significant (P<0.05).Conclusion Caveolin-1 can reduce the degree of endotoxin-induced lung injury, and can inhibit the fibrosis process, and has a certain lung protective effect.

参考文献/References:

[1]耿平,凌冰玉,李玉洁,等.Claudin蛋白在急性肺损伤中的研究进展[J].中华急诊医学杂志,2019,28(1):116-120.[2]Ramirez MI,Pollack L,Millien G,et al.The Isoform of Caveolin-1 Is a Marker of Vasculogenesis in Early Lung Development[J].Journal of Histochemistry&Cytochemistry,2002,50(1):33-42.[3]Razani B,Zhang XL,Bitzer M,et al.Caveolin-1 Regulates Transforming Growth Factor(TGF)-beta/SMAD Signaling through an Interaction with the TGF-beta Type I Receptor[J].Journal of Biological Chemistry,2001,276(9):6727-6738.[4]孙林清,周倩文,王发选.转化生长因子β1对肺成纤维细胞中平滑肌肌动蛋白表达的影响[J].宁夏医科大学学报,2019,41(5):461-464.[5]Lv XJ,Li YY,Zhang YJ,et aI.over-expression of caveolin-1 aggravate LPS -induced infIammatory response in AT-1 cells via up -reguiation of cPLA2/p38 MAPK[J].InfIamm Res,2010,59(7):531-541.[6]李琦,尹婕,冉庆森,等.急性肺损伤模型中连花清瘟胶囊对巨噬细胞趋化能力的药效与机制研究[J].中国中药杂志,2019(11):2317-2323.[7]董广通,张解玉,侯炜.中医药治疗放射性肺纤维化临床研究进展[J].中国中医药信息杂志,2019(4):141-144.[8]Goswami KK,Ghosh T,Ghosh S,et al.Tumor promoting role of anti-tumor macrophages in tumor microenvironment[J].Cellular Immunology,2017:S0008874917300618.[9]Jin Y,KimHP,Chi M,et al.DeIetion ofcaveolin -1 protects against oxidative Lung injury via up-regulation of hemeoxygenase-1[J].Am J Respir Cell Mol Biol,2008,39(2):171-179.

相似文献/References:

[1]温占兵.血管生成素-1水平变化预测脓毒症急性肺损伤的价值[J].医学信息,2018,31(13):95.[doi:10.3969/j.issn.1006-1959.2018.13.027]
　WEN Zhan-bing.The Value of Angiopoietin-1 Level Change in Predicting Acute Lung Injury in Sepsis[J].Medical Information,2018,31(13):95.[doi:10.3969/j.issn.1006-1959.2018.13.027]
[2]杨 雍,吕汝琦,刘 丹.早期无创正压通气对重症急性胰腺炎合并肺损伤的保护作用机制[J].医学信息,2019,32(03):55.[doi:10.3969/j.issn.1006-1959.2019.03.018]
　YANG Yong,LV Ru-qi,LIU Dan.Protective Mechanism of Early Noninvasive Positive Pressure Ventilation on Severe Acute Pancreatitis Complicated with Lung Injury[J].Medical Information,2019,32(13):55.[doi:10.3969/j.issn.1006-1959.2019.03.018]
[3]彭 燕.牛磺酸对LPS诱导小鼠急性肺损伤的治疗作用[J].医学信息,2020,33(03):79.[doi:10.3969/j.issn.1006-1959.2020.03.023]
　PENG Yan.Therapeutic Effect of Taurine on LPS-induced Acute Lung Injury in Mice[J].Medical Information,2020,33(13):79.[doi:10.3969/j.issn.1006-1959.2020.03.023]
[4]陈友莲,洪澄英,刘晓君,等.不同呼吸支持模式对重症肺炎所致急性呼吸窘迫综合症患者预后的影响[J].医学信息,2021,34(06):126.[doi:10.3969/j.issn.1006-1959.2021.06.032]
　CHEN You-lian,HONG Cheng-ying,LIU Xiao-jun,et al.The Influence of Different Respiratory Support Modes on the Prognosis of Patients with Acute Respiratory Distress Syndrome Caused by Severe Pneumonia[J].Medical Information,2021,34(13):126.[doi:10.3969/j.issn.1006-1959.2021.06.032]
[5]贾 静.综合护理对肺纤维化合并肺部感染及呼吸衰竭患者临床疗效及肺功能的影响[J].医学信息,2021,34(08):189.[doi:10.3969/j.issn.1006-1959.2021.08.053]
　JIA Jing.The Effect of Comprehensive Nursing Care on the Clinical Efficacy and Lung Function of Patients with Pulmonary Fibrosis Combined with Pulmonary Infection and Respiratory Failure[J].Medical Information,2021,34(13):189.[doi:10.3969/j.issn.1006-1959.2021.08.053]
[6]殷佳辉,王 琪,孙宇辰,等.胎牛肺间充质干细胞对脂多糖介导小鼠急性肺损伤治疗的研究[J].医学信息,2021,34(10):78.[doi:10.3969/j.issn.1006-1959.2021.10.022]
　YIN Jia-hui,WANG Qi,SUN Yu-chen,et al.Research on Fetal Bovine Lung Mesenchymal Stem Cells on Lipopolysaccharide-induced Acute Lung Injury in Mice[J].Medical Information,2021,34(13):78.[doi:10.3969/j.issn.1006-1959.2021.10.022]
[7]袁 牧,邢 伟,徐 祥.脓毒症患者发生急性肺损伤的机制和生物标记物研究[J].医学信息,2023,36(16):1.[doi:10.3969/j.issn.1006-1959.2023.16.001]
　YUAN Mu,XING Wei,XU Xiang.Study on the Mechanism and Biomarkers of Acute Lung Injury in Patients with Sepsis[J].Medical Information,2023,36(13):1.[doi:10.3969/j.issn.1006-1959.2023.16.001]

更新日期/Last Update: 1900-01-01